8-K: ModivCare Issues Additional $50.165 Million in Second Lien Notes Following Stockholder Approval

ModivCare Inc. issues an additional $50.165 million in Second Lien Senior Secured PIK Toggle Notes due 2029, following stockholder approval of the Coliseum Transactions.

Summary

• ModivCare Inc. has issued an additional $50.165 million in 5.000%/10.000% Second Lien Senior Secured PIK Toggle Notes due 2029.
• This issuance is governed by a First Supplemental Indenture, dated March 14, 2025, among ModivCare, its guarantors, and Ankura Trust Company, LLC.
• The additional notes were issued pursuant to a Purchase and Exchange Agreement dated January 9, 2025, with Coliseum Capital Partners, L.P. and Blackwell Partners LLC Series A.
• Stockholders approved the Coliseum Transactions at a Special Meeting held on March 3 and reconvened on March 13, 2025.
• The additional notes will be consolidated with the initial $251.0 million of Second Lien Notes issued on March 7, 2025, forming a single class.
• Interest on the additional notes will accrue from October 1, 2024, with the first Interest Payment Date being April 1, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The company has successfully issued additional debt and received stockholder approval for a key transaction. However, the impact of the debt on the company's financials needs to be further analyzed.

Positives

• The issuance of additional notes provides ModivCare with additional capital.
• Stockholder approval of the Coliseum Transactions removes a potential hurdle for the company.
• The notes rank pari passu with the initial notes, maintaining their status.

Future Outlook

The document does not contain specific forward-looking statements beyond the issuance of the notes.

Industry Context

Issuing debt can be a common practice for companies to raise capital for various purposes, such as acquisitions, investments, or refinancing existing debt. The specific terms of the notes, such as the interest rate and maturity date, will be important factors in assessing the impact on ModivCare's financial position.

Comparison to Industry Standards

• It is difficult to compare this specific debt issuance to industry standards without knowing the specific use of funds and ModivCare's overall capital structure.
• Comparable companies in the healthcare services sector often utilize debt financing, but the terms and conditions vary widely based on credit ratings, market conditions, and company-specific factors.
• Companies like UnitedHealth Group, CVS Health, and Humana also issue debt, but their scale and financial profiles are significantly different from ModivCare.

Stakeholder Impact

• Shareholders: The issuance of additional debt could impact shareholder value depending on the use of funds and the company's ability to service the debt.
• Creditors: The new notes rank pari passu with existing notes, potentially impacting the risk profile of existing creditors.
• The investors benefit from the transaction.

Key Dates